|
|
|
|
|
|
|
|
The Latest Research, Commentary, and News from Health Affairs
Monday, July 20, 2020
|
|
|
|
|
|
|
EYE ON HEALTH REFORM
Contraceptive Mandate, ACA Final Rules, And
COVID-19
By Katie Keith
Katie Keith reviews several key Supreme Court decisions pertaining to the Affordable Care Act (ACA). These include the court’s 7–2 decision in Little Sisters of the Poor Saints Peter and Paul Home v. Pennsylvania, upholding two Trump-era rules that broadly exempt employers from complying with the contraceptive mandate of the ACA when they object for religious or moral reasons. In addition, Keith notes new federal
guidance on the ACA, identifying ACA requirements that are now being delayed as a result of COVID-19.
Read More >>
|
|
|
TODAY ON THE BLOG
COVID-19
By Leana S. Wen and Nakisa B. Sadeghi
As states begin to reopen, and we look ahead to the next stage of the COVID-19 pandemic, policy makers, health systems, and public health authorities should turn attention to concrete steps that can be taken to ensure that recurring patterns of health disparities do not repeat themselves. It is not sufficient to advance policy or
strategy without an explicit focus on equity. Read More >>
FOLLOWING THE ACA
ACA Litigation Round-Up: Part I
By Katie Keith
This post summarizes the recent Affordable Care Act (ACA)–related Supreme Court decisions and the latest in California v. Texas. A second post will discuss the status of long-standing ACA-related lawsuits and highlight newer lawsuits over ACA implementation. A third post will focus on the resolution of lawsuits over unpaid risk corridors payments. Read More >>
|
|
|
IN THE JOURNAL
CONSIDERING HEALTH
SPENDING
Lessons From The Impact Of Price Regulation On The Pricing Of Anticancer Drugs In Germany
By Victoria D. Lauenroth, Aaron S. Kesselheim, Ameet Sarpatwari, and Ariel D. Stern
Under the 2011 German Pharmaceutical Market Restructuring Act, manufacturers set the prices of newly authorized drugs during their first year on the market. Benefit assessments are carried out during this year and then used in price
negotiations between manufacturers and representatives of the country’s statutory health insurers. Using data on fifty-seven anticancer drugs launched in Germany from 2002 to 2017, Victoria Lauenroth and coauthors found that implementation of the act was associated with drug prices being more closely aligned with clinical benefit. Read More >>
|
|
|
|
|
A CLOSER LOOK—The Innovation Center
On Health Affairs Blog, Jeff Micklos and coauthors enumerate the key drawbacks of the programs conducted by the Center for Medicare and Medicaid Innovation (the Innovation Center) in recent years. Highlighting the importance of a clear and public vision; the balance of innovation, interaction, and scale of certain projects; and adjusting financial expectations, the
authors detail how the Innovation Center could accelerate positive change with appropriate reforms.
|
|
|
|
|
|
|
|
|
About Health Affairs
Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.
Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States
Privacy Policy
|
|
|
|
|
